Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-13

Clinical Trial Update: Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial comparing risperidone, olanzapine, and quetiapine for mania in children and adolescents with Bipolar I or II disorder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)
  • SEROQUEL (QUETIAPINE)
  • Zyprexa (olanzapine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bipolar Spectrum Disorder | Phase 4 | Status: COMPLETED